Advanced Kras G12d Mutant Solid Tumors clinical trials

Explore recruiting advanced kras g12d mutant solid tumors clinical trials.

Recruiting advanced kras g12d mutant solid tumors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Kras G12d Mutant Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2, Open-label Study of VS-7375, a KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and in Combination, in Patients with Advanced KRAS G12D-Mutant Solid Tumors

Italy, France, Germany, Belgium, Spain, Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Advanced Kras G12d Mutant Solid Tumors trials by city

Advanced Kras G12d Mutant Solid Tumors in Toronto Advanced Kras G12d Mutant Solid Tumors in Vancouver Advanced Kras G12d Mutant Solid Tumors in Montreal Advanced Kras G12d Mutant Solid Tumors in Calgary Advanced Kras G12d Mutant Solid Tumors in Edmonton Advanced Kras G12d Mutant Solid Tumors in Ottawa Advanced Kras G12d Mutant Solid Tumors in Winnipeg Advanced Kras G12d Mutant Solid Tumors in Quebec City Advanced Kras G12d Mutant Solid Tumors in Hamilton Advanced Kras G12d Mutant Solid Tumors in Kitchener Advanced Kras G12d Mutant Solid Tumors in London Advanced Kras G12d Mutant Solid Tumors in Halifax Advanced Kras G12d Mutant Solid Tumors in New York Advanced Kras G12d Mutant Solid Tumors in Los Angeles Advanced Kras G12d Mutant Solid Tumors in Chicago Advanced Kras G12d Mutant Solid Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease